Jump to content Jump to main menu Jump to sub menu

Archive

10 July 2015 - Multi-national asthma study award

QED announces the award of a multi-national asthma study for a European biotech company.The study which will be conducted in 5 countries is set out to recruit 200 patients. Chief Executive Thomas Ogorka comments:
Read more »

16 February 2015 - Our rare disease division orphan reach is sponsoring the WODC 2015

orphan reach

QED’s rare disease division orphan reach is sponsoring the World Orphan Drug Congress 2015 in Washington D.C. from 22-24 April. Feel free to visit us at stand #6